Published January 2014 | Version v1
Journal article

Imaging the myocardium at risk with 99mTc-lactadherin administered after reperfusion in a porcine model

  • 1. Institute for Clinical Medicine, Aarhus University, Aarhus (Denmark)
  • 2. Protein Chemistry Laboratory, Department of Molecular Biology and Genetics, Aarhus University, Aarhus (Denmark)
  • 3. Department of Cardiology, Aarhus University Hospital, Skejby (Denmark)
  • 4. Department of Nuclear Medicine, Aarhus University Hospital, Aarhus (Denmark)

Description

Introduction: Phosphatidylserine is translocated from the inner to the outer leaflet of the plasma membrane in the early stages of apoptosis and necrosis and in reversibly injured cells. In rabbit hearts, ischemia followed by reperfusion results in exposure of phosphatidylserine on myocytes unaffected by apoptosis or necrosis. Lactadherin was recently introduced as a highly sensitive phosphatidylserine ligand. We hypothesized that ischemic myocardial cell damage can be identified by radio-labeled lactadherin and that the ischemic area at risk (AAR) can be visualized retrospectively after reperfusion. Methods: Left anterior descending coronary artery in pigs was occluded for 20 minutes, 45 minutes or 45 minutes preceded by ischemic preconditioning. In all three groups, 99mTc-lactadherin was injected intravenously 30 minutes after reperfusion. The AAR was demarcated by Evans blue and the infarct size by 2,3,5,-triphenyltetrazodium chloride staining. Results: The regional myocardial uptake of 99mTc-lactadherin closely correlated with the AAR (r = .83, P = .001). The area of 99mTc–lactadherin uptake was unaltered by a shorter duration of ischemia and ischemic preconditioning (P = .23) despite significantly different infarct development (P = .001). Conclusion: The results suggest that 99mTc–lactadherin can be used as a sensitive marker for AAR imaging when injected 30 minutes after reperfusion following acute ischemia

Availability note (English)

Available from http://dx.doi.org/10.1016/j.nucmedbio.2013.09.004

Additional details

Identifiers

DOI
10.1016/j.nucmedbio.2013.09.004;
PII
S0969-8051(13)00203-5;

Publishing Information

Journal Title
Nuclear Medicine and Biology
Journal Volume
41
Journal Issue
1
Journal Page Range
p. 114-119
ISSN
0969-8051
CODEN
NMBIEO

Optional Information

Copyright
Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.